A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Sponsor: City of Hope Medical Center
New Haven, CT · +10 more sites
19 recruiting type 1 diabetes studies with a site in New Haven, CT.
Sponsor: City of Hope Medical Center
New Haven, CT · +10 more sites
Sponsor: Sanofi
New Haven, CT · +33 more sites
Sponsor: Medtronic MiniMed, Inc.
New Haven, CT · +17 more sites
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
New Haven, CT · +11 more sites
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
New Haven, CT · +5 more sites
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
New Haven, CT · +13 more sites
Sponsor: Mannkind Corporation
New Haven, CT · +9 more sites
Sponsor: Yale University
New Haven, CT
Sponsor: Insulet Corporation
New Haven, CT · +10 more sites
Sponsor: Yale University
New Haven, CT
Sponsor: Yale University
New Haven, CT
Sponsor: Zucara Therapeutics Inc.
New Haven, CT · +37 more sites
Sponsor: Icahn School of Medicine at Mount Sinai
New Haven, CT · +12 more sites
Sponsor: Sanofi
New Haven, CT · +36 more sites
Sponsor: Yale University
New Haven, CT
Sponsor: Yale University
New Haven, CT
Sponsor: Yale University
New Haven, CT
Sponsor: Yale University
New Haven, CT
Sponsor: University of South Florida
New Haven, CT · +16 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.